Adriamycin is the most extensively studied of a family of highly fluorescent anthracycline antibiotics produced by several Streptomyces species, first reported in 1967 and later approved for human therapeutic used as an anti-tumor agent for the treatment of a wide range of cancers. Adriamycin has also been reported to exhibit anti-HIV and antibacterial activity. The mode of action of Adriamycin is thought to be due to intercalation of DNA and inhibition of nucleic acid synthesis.
本公司网站所展示销售的产品仅供科研!
沪公网安备 31011202007337号